Benzinga's Top #PreMarket Losers

shares dropped 26.27% to $5.50 in pre-market trading. Spectrum Pharma confirmed that the court has ordered a judgment in favor of defendant Sandoz in Fusilev patent litigation. Roth Capital downgraded Spectrum Pharmaceuticals from Buy to Neutral.

shares dropped 4.60% to $8.50 in pre-market after falling 0.64% on Friday.

fell 4.32% to $67.31 in pre-market trading after jumping 9.44% on Friday.

shares declined 3.03% to $7.35 in pre-market trading. Breitburn Energy Partners is expected to report Q4 results on March 3, 2015.

shares fell 2.35% to $12.45 in pre-market trading after rising 2.08% on Friday. On February 20, Linnco said that it has entered into an equity distribution agreement to sell shares with aggregate offering price of up to $500 million.